Background: Anecdotally, aloe vera is used to treat gastric ulceration, although no studies have yet investigated its efficacy in horses. Objectives: To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome. Study design: Randomised, blinded clinical trial. Methods: Forty horses with grade ≥2 lesions of the squamous and/or glandular mucosa were randomly assigned to one of two groups. Horses received either aloe vera inner leaf gel (17.6 mg/kg bwt) b.i.d. or omeprazole (4 mg/kg bwt) s.i.d. for approximately 28 days, after which a repeat gastroscopic examination was performed to determine disease resolution. Horses with persistent lesions were offered a further 28 days of treatment with omeprazole (4 mg/kg bwt s.i.d.) and were re-examined on completion of treatment. Results: Efficacy analyses were based on 39 horses that completed the trial. Equine squamous gastric disease (ESGD) was observed in 38 horses; improvement and healing rates in these horses were 56% and 17%, respectively, in the aloe vera group, and 85% and 75%, respectively, in the omeprazole group. Healing was less likely to occur in horses with prolonged gastric emptying. Equine glandular gastric disease (EGGD) was less common than ESGD (n = 14) and numbers were too small to perform meaningful statistical analyses. The hypothesis that aloe vera would be noninferior to omeprazole was not supported. Main limitations: No placebo control group was included. Limited numbers preclude any comment on the efficacy of aloe vera in the treatment of EGGD. Conclusions: Treatment with aloe vera was inferior to treatment with omeprazole.
Introduction
Equine gastric ulcer syndrome (EGUS) is a recurrent problem that affects large proportions of intensively trained and pleasure horse populations [1] [2] [3] [4] . Lesions may affect both the squamous and glandular regions of the stomach [5] , although the risk factors associated with the development of lesions in these regions are likely to differ [6] . Recent recommendations suggest that the terms 'equine squamous gastric disease' (ESGD) and 'equine glandular gastric disease' (EGGD) should be used in order to describe the region affected more specifically [6] . Irrespective of the cause and location, the mainstay for treatment of EGUS is aimed at reducing acid secretions and increasing the pH of the gastric juices [7] . The current drug of choice is omeprazole, a proton pump inhibitor. Omeprazole is absorbed by the small intestine, where it is transported into the bloodstream. Once it has migrated to the glandular mucosa, omeprazole acts by binding to the H + /K + ATPase proton pump on the parietal cells and prevents the secretion of H + ions into the gastric lumen [7, 8] , thus inhibiting acid secretion and consequently elevating gastric pH [9] .
Although omeprazole has been shown to be highly effective in the treatment of ESGD, the condition will recur if horses continue to be exposed to the risk factors associated with its development. Management changes such as increasing the roughage content of the diet, reducing the amount of concentrates fed, increasing the frequency of feeding and reducing exercise intensity are suggested to help prevent the recurrence of ESGD [10, 11] . However, evidence to support these claims is lacking and lesion redevelopment is common. After an initial course of treatment with omeprazole, continued therapy at a lower dose has been found to prevent recurrence of ESGD in most horses [12] . Successful treatment of EGGD is more challenging, with recent studies reporting that only 21-50% of lesions healed with 28-35 days of omeprazole treatment at a dose of 4 mg/kg bwt s.i.d. [13, 14] . Horses with EGGD may therefore require more prolonged acid suppression and the addition of a mucosal protectant such as sucralfate [6] .
A potential alternative treatment for EGUS is aloe vera. The inner leaf gel of the aloe vera plant has been reported to be effective in the prevention and treatment of gastric ulcers in man and in animals in experimental models [15] [16] [17] . Its anti-ulcer properties have been attributed to a variety of possible mechanisms including anti-oxidant activity, anti-inflammatory properties, cytoprotective and mucus-stimulatory effects, and its ability to regulate gastric acid production [18] [19] [20] [21] [22] .
Although anecdotally aloe vera has been used to treat EGUS, no studies have yet investigated its efficacy. The aim of this study was to compare the efficacy of aloe vera inner leaf gel with that of omeprazole. It was hypothesised that aloe vera would be noninferior to omeprazole in the treatment of EGUS.
Materials and methods

Horse recruitment and initial examination
Horses were recruited from the University of Adelaide teaching herd and from clinical cases presented to the university's Equine Health and Performance Centre with clinical signs suggestive of EGUS, or a previous diagnosis of EGUS. Exclusion criteria included: treatment with any anti-ulcer medication in the previous 7 days, and a history of recent illness or treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) within the previous 7 days.
Background information about each animal including signalment, use, management and clinical history was recorded. Each horse underwent a general physical examination and a gastroscopic examination. Horses were fasted for 12-14 h and water was withheld for 2 h prior to the examination. Horses were weighed and sedated with 0.01 mg/kg bwt detomidine i.v. The gastroscopic examination was performed using a 320-cm flexible videoendoscope (Olympus GIF-Q180 a ) that was passed through a preplaced tube inserted via the nares into the cranial oesophagus. The stomach was insufflated with air and the mucosa was flushed with water to remove any food material adhering to the stomach wall. If food remaining in the stomach was too great to allow adequate observation of the squamous and glandular mucosa, gastric emptying was considered to be prolonged and the gastroscopic examination was repeated after an extended period of fasting. Horses were either fasted for another 4-6 h if the gastroscopy was repeated on the same day, or fasted for 16-20 h if this took place on another occasion. Video-recordings were made of all examinations to allow for review at a later date.
The gastroscopic examination included observation of six key regions: the squamous fundus; the margo plicatus right; the margo plicatus greater curvature; the lesser curvature; the glandular fundus, and the pylorus. Each region was graded on a scale of 0-4, as recommended by the EGUS council [5] , based on consensus between the two clinicians. Maximal grades were recorded for both the squamous and glandular regions. Horses were enrolled into the trial if they had a maximal grade of ≥2 in any region.
Group allocation and blinding
The trial was designed as a parallel-group, blinded, randomised clinical trial. Horses were stratified according to use (teaching vs. client-owned horses) and randomly allocated to either the aloe vera or omeprazole treatment group using a random number generator. One investigator was responsible for randomisation, as well as for the administration of treatment to the teaching horses. The other two investigators performed the gastroscopic examinations and remained blinded until final scoring had been completed and recorded. Owners were not blinded to the treatment groups but were asked not to discuss treatment with the other investigators.
Treatment
Horses in the aloe vera treatment group were treated with a dehydrated inner leaf aloe vera powder b , which was reconstituted to a paste (approximately 10 mL) by the addition of water and administered orally. The dose rate of 17.6 mg/kg bwt b.i.d. was based on the dose rate (200 mg/kg bwt b.i.d.) used in previous studies in rats [21] [22] [23] converted to a dose rate for horses using allometric scaling based on body surface area (BSA) [24, 25] and calculated as follows:
horse dose rate (mg/kg bwt) ¼ rat dose (mg/kg bwt) Â ðrat K m = horseK m Þ where rat K m = 6 [24] , and horse K m is calculated by bodyweight divided by BSA (m 2 ), and BSA is calculated using as: (bwt [g] 2/3 9 10.5)/10 4 [25] .
Horses in the omeprazole treatment group received 4 mg/kg bwt of a commercially available buffered omeprazole paste (Omoguard â Paste c ) s.i.d. Owners were instructed to give treatments approximately 30 min before morning and afternoon meals for aloe vera and before the morning meal for omeprazole. For horses with access to ad libitum forage, owners were instructed to give the treatments at the same time each day, early in the morning and late in the afternoon. Owners were advised to maintain their usual management practices during the course of the trial.
Repeat examinations
Where possible, follow-up gastroscopic examinations were carried out on day 28. If examination was not possible on that day, horses remained on treatment until the gastroscopic examination was performed. Owners were asked a series of questions at follow-up examinations to ascertain details of any difficulties encountered with treatment, changes in management, development of new problems with the horse, such as injury or illness, and any other medications administered during the treatment period. The repeat gastroscopic examination was carried out as described above and lesions were graded in the same way. Lesions were said to have improved if they had decreased by at least one grade in either the squamous or glandular regions. Healing was said to have occurred if a grade of ≤1 was achieved. Horses found to have a maximum lesion grade of ≥2 at the follow-up examination were offered additional treatment with omeprazole (at a dose of 4 mg/kg bwt s.i.d. for 28 days), regardless of the treatment group to which they had been allocated initially, and returned for a second follow-up examination on day 56.
Data analysis
The trial was designed to test the noninferiority of aloe vera compared with omeprazole by assessing the proportions of horses showing improvements in ulcer grade. A power calculation was performed based on previous work [26, 27] . With a one-sided test of proportions with a noninferiority margin of 20% and an assumed improvement rate of 96%, 17 horses per treatment group would be required to achieve a power of 90%, with a significance level of 5%. A total of 40 horses were recruited to allow for a 15% dropout rate.
Two statistical programs were used for data analysis: IBM SPSS Statistics for Windows Version 22.0 d and an online statistical software package (WinPepi Version 11.65 e ). The level of significance was set at P<0.05. Baseline population characteristics were compared between groups. The characteristics examined included age, sex, breed, weight, body condition score, feeding practices (forage only vs. forage plus concentrates), use (teaching vs. client-owned) and exercise level (not in work, light, moderate or heavy work). Data were checked for normality using the Shapiro-Wilk test. Data for bodyweight were normally distributed and comparisons between groups were made using an unpaired t test. Other data were not normally distributed and comparisons between groups were made using nonparametric tests including the Mann-Whitney U test and chi-squared test (or Fisher's exact test as appropriate).
Baseline squamous and glandular lesion grades were compared between groups using Fisher's exact test. The time between baseline and follow-up examination (days) was compared using a Mann-Whitney U test. A Wilcoxon signed-rank test was used to assess changes in maximal lesion grades within groups over time and a Mann-Whitney U test was used to evaluate changes in maximal lesion grades between groups (aloe vera or omeprazole) before and after treatment.
All efficacy analyses were calculated on the 'per protocol' population. Noninferiority was calculated using WinPepi Compare 2 e . Chi-squared tests (or Fisher's exact tests, as appropriate) were used to assess improvement and healing rates overall and for squamous and glandular lesions separately. Jeffrey's method was used to calculate confidence intervals (CIs) for differences between treatment groups. The efficacy of aloe vera could be considered noninferior to that of omeprazole if the lower limit of the one-sided 95% CI was equal to or greater than À20%. Risk factors for nonhealing after the second treatment period were investigated using Fisher's exact test.
Results
Horses
A total of 78 horses were screened for eligibility for the trial. Of these, 40 were enrolled in the study (Fig 1) . Twenty horses were assigned to each group, although one horse was withdrawn from the aloe vera group because of an unrelated illness. Two horses (one in each group) developed a single episode of colic during the study period but were included in the final analysis. No other adverse events were recorded during the study.
The 19 horses in the aloe vera treatment group had a mean AE s.d. bodyweight of 497 AE 63 kg and a mean AE s.d. age of 9.2 AE 5.9 years. The group consisted of 15 mares and four geldings varying in breed and use. The 20 horses in the omeprazole treatment group had a mean AE s.d. bodyweight of 487 AE 65 kg and a mean AE s.d. age of 9.4 AE 5.8 years. The group consisted of eight mares and 12 geldings of varying breeds and use. There were no significant differences between groups in breed (P = 0.70), exercise level (P = 0.37), use (P = 0.61), feeding practices (P = 0.87), age (P = 0.71), weight (P = 0.65) or condition score (P = 0.50). However, there were more mares in the aloe vera group (P = 0.02).
Lesion grades
The entire squamous mucosa was effectively observed in all horses. Residual fluid prevented observation of the most ventral portion of the Equine Veterinary Journal 50 (2018) 34-40 © 2017 EVJ Ltd glandular body and it was not possible to view the pylorus in three horses at the initial examination and five horses at the second examination. Eight horses were considered to have prolonged gastric emptying at the first examination and underwent a second examination after an extended period of fasting, as described previously. Of these horses, it was still not possible to view the pylorus in one case. After treatment, three horses again required a second examination and it was not possible to view the pylorus in three cases.
The distribution of lesion grades for both the squamous and glandular regions at enrolment, in the 39 horses that completed the trial, is shown in Table 1 . All except one horse (97%, 95% CI 89-100%) had squamous lesions of grade ≥2. Glandular lesions were less common (n = 14; 36%, 95% CI 22-50%) and no horses had grade 4 lesions in this region. Maximum baseline grades for the squamous and glandular regions did not differ significantly between the treatment groups (P = 0.85 and P = 1.0, respectively) (Fig 2) . The mean AE s.d. time to the first follow-up examination was 30.1 AE 2.7 days and 29.1 AE 1.0 days in the aloe vera and omeprazole treatment groups, respectively, and did not differ between groups (P = 0.43).
Median and interquartile ranges for squamous lesion grades at baseline and following approximately 28 days of treatment with either aloe vera or omeprazole are shown in Fig 3. When changes in maximal squamous lesion grades were assessed within groups, no difference was found in the aloe vera group between baseline and the follow-up examination (P = 0.073). However, there was a difference in the omeprazole group (P<0.001). There was no difference between groups in maximum squamous lesion grade at the baseline examination (P = 0.513). However, there was a difference between treatment groups following approximately 28 days of treatment (P = 0.001). No statistical analysis of outcomes in glandular lesions was performed because the numbers of horses with EGGD were low.
Efficacy analyses
The per protocol population comprised 39 horses (19 in the aloe vera group and 20 in the omeprazole group). Of these horses, 38 had evidence of ESGD and 14 had EGGD at the start of the study. The response to treatment is shown in Table 2 . Rates of improvement in squamous lesions were 56% (95% CI 33-76%) in the aloe vera group and 85% (95% CI 65-96%) in the omeprazole group, whereas healing rates were 17% (95% CI 5-38%) in the aloe vera group and 75% (95% CI 54-90%) in the omeprazole group. Rates of improvement and healing in glandular lesions were identical as the criteria for both improvement and healing were met in all horses that showed improvement. Following treatment, rates of improvement and healing were 60% (95% CI 21-91%) in the aloe vera group and 86% (95% CI 50-98%) in the omeprazole group.
The lower limit of the 95% CI for the difference in proportions was greater than À20% and thus did not support the current hypothesis that aloe vera would be noninferior to omeprazole.
Second follow-up examination
Following the initial study period, 22 horses (16 in the aloe vera group and six in the omeprazole group) received further treatment with omeprazole at 4 mg/kg bwt s.i.d. for approximately 28 days. These included 19 horses that did not show complete squamous lesion resolution (grade ≥2) at 28 days and one horse that developed new squamous lesions during the study period. One horse with incomplete resolution of ESGD did not receive a subsequent course of omeprazole. Six horses also had unresolved (n = 4) or newly developed (n = 2) EGGD and two horses had glandular lesions only (that were not present at the initial examination).
Twenty-one horses returned for a second follow-up examination after approximately 28 days. This revealed that squamous lesions had healed in The pylorus was not viewed in three cases.
seven of 19 horses (37%, 95% CI 18-59%) and glandular lesions had healed in five of seven horses (71%, 95% CI 35-94%) ( Table 3) . Squamous healing was significantly less likely in horses with prolonged gastric emptying (none of six vs. seven of 13 horses; P = 0.04).
Discussion
This study is the first to assess the efficacy of aloe vera inner leaf gel for the treatment of EGUS. The data did not support the hypothesis that aloe vera would be noninferior to omeprazole. Nevertheless, 56% of cases showed some improvement in squamous lesion severity following 28 days of treatment with aloe vera, which represents a proportion greater than those described in previous placebo-controlled studies [26, 27] . Healing rates were, however, considerably lower, with only 17% of squamous lesions healed after 28 days of treatment. In comparison, a study by MacAllister et al. [26] reported that 32.4% of horses receiving a placebo showed improvement of squamous lesions and 8.9% achieved healing. Similarly, Andrews et al. [27] demonstrated that only 4% of horses with squamous lesions had achieved healing after 4 weeks of sham treatment.
No placebo or untreated control group was included in the current study because to do so would be considered unethical and would have been likely to make owners reluctant to enrol their horses into the study. A study of NSAID-induced peptic ulcers in rats found that animals pretreated with aloe vera at a dose of 200 mg/kg bwt for 5 days showed reduced signs of mucosal injury compared with untreated controls, although the effect was not as marked as in animals treated with omeprazole [17] . However, others have shown that pretreatment with aloe vera was not effective against gastric lesion formation [28] . Aloe vera has been shown to produce dose-dependent reductions in the severity and incidence of gastric lesions caused by the application of acetic acid when given as a preventive measure in rats [18] and hence the dose of aloe vera is likely to be important.
Mahattanadul [18] investigated the healing effects of different doses and formulations of aloe vera in rats with induced gastric ulcers and reported a healing rate of 42.9% with the use of fresh aloe vera at a dose of 200 mg/ kg bwt b.i.d. for 12 days, which was comparable with healing rates achieved using cimetidine (100 mg/kg bwt b.i.d.), and a lower healing rate (29.7%) following treatment with a lower dose (100 mg/kg bwt b.i.d.) of fresh aloe vera. Reconstituted aloe vera powder (200 mg/kg bwt b.i.d.) given for 8 days also showed healing effects similar to those achieved with sucralfate (200 mg/kg bwt b.i.d.), at 40 and 44%, respectively [18] .
The dose of aloe vera used in the present study was based on a dose of 200 mg/kg bwt b.i.d. in rats and was extrapolated to horses based on calculations of BSA [24] . The possibility that a higher dose would have resulted in higher rates of improvement and healing cannot be ruled out, although the dose used in the current study was higher than that commonly administered to horses and higher than that recommended by the manufacturer.
Stomach morphology in the rat and horse is similar: in both cases the stomach is divided into a glandular and stratified squamous nonglandular portion, unlike the human stomach, which is glandular [29] . Gastric ulceration in rats can be induced experimentally via a number of methods, including the administration of chemical agents and the direct application of necrotising agents [30] . Usually, lesions are induced in the antrum or fundus of the glandular portion of the stomach in order to model peptic ulceration in man. Studies of aloe vera in rats have therefore focused on glandular lesions. However, aloe vera has also been used to treat other ulcerative lesions of the gastrointestinal tract, including oral ulcers [31, 32] , radiation-induced mucositis [33] and gastroesophageal reflux disease [34] .
In the present study, the baseline examination revealed that squamous lesions were more common than glandular lesions, as previously reported in horses [35] . Most lesions occurred adjacent to the margo plicatus and the lesser curvature was more likely to be affected than other regions, also as previously reported [36] . An analysis of population characteristics found that more mares were allocated to the aloe vera treatment group. However, previous studies reported that gender does not have effects on ulcer development or healing rates [2, 37] . Therefore, it was concluded that this was unlikely to have influenced the outcome of the study.
The efficacy of omeprazole for treatment of EGUS has been studied widely. The rate of improvement of squamous lesions treated with omeprazole in this study was 85% and the healing rate was 75% following approximately 28 days of treatment. These rates are lower than those reported in early trials of omeprazole, in which improvement rates of 99% [26] and healing rates of 86.7% [26] to 100% [38] were recorded in ESGD. However, the current findings are similar to those of other studies, in which healing rates of 67-77% for squamous lesions are consistently reported [13, 27, 39] .
In the current study, six of seven horses with glandular lesions were healed following approximately 28 days of omeprazole treatment, which represents a higher rate than previously reported [13, 14] . However, the small number of horses with EGGD in this study limits the ability to draw conclusions regarding the efficacy of omeprazole or aloe vera in the treatment of glandular lesions and hence further studies in larger numbers of horses with glandular lesions are required. Glandular lesions developed in four horses during the study period, despite treatment with either omeprazole or aloe vera (in two horses in each treatment group). The factors contributing to glandular lesion development and treatment are still poorly understood and require further investigation.
An interesting finding concerns the discovery that the healing rate of squamous lesions was only 37% in the group of horses that received a second course of treatment with omeprazole at the repeat examination at day 56. This is considerably lower than in the omeprazole group during the first part of the study and lower than reported by others [6] . It suggests that healing is impaired or re-injury occurs more rapidly in some horses and hence it would be useful to identify the factors that play a role in this. Sykes et al. [40] recently showed wide variation in the oral bioavailability of omeprazole in horses in a study in which three of 12 horses were described as poor absorbers. This could be the result of poor absorption and/or changes in the rate of elimination, as is the case in man [41] .
Poor absorption may be related to feeding practices. Results of studies into the effect of feeding on the efficacy of omeprazole have been equivocal, although there is some evidence to suggest that absorption may be better in fasted horses [42] and in horses fed a high grain-low fibre diet, compared with horses fed ad libitum hay [43] . Furthermore, it has been found that the efficacy of omeprazole for raising intragastric pH is lower in horses maintained on a hay diet compared with those fed a high grain-low fibre diet [44] . The present study found no difference in healing rates between horses fed concentrates and forage and those fed a diet of forage alone. However, squamous lesion healing was less likely to occur in horses with prolonged gastric emptying. There are several mechanisms through which prolonged gastric emptying may interfere with healing of gastric lesions. Feed retained within the stomach may conceivably inhibit omeprazole absorption or may mechanically influence healing and/or cause new lesion formation. Previously, feeding of straw as the only forage was found to be a risk factor for EGUS [11] . Many horses in South Australia are fed oaten hay, which is quite coarse and very similar to materials that would be classified as straw in other parts of the world. This may have contributed to the development of ulcers and interfered with their healing. Alternatively, the prolonged emptying could be a result of gastric lesions. The horses in the current study were fasted for 12-14 h prior to gastroscopic examination, which should have provided enough time for the stomach to empty, given that Stokes et al. [45] reported that gastric emptying occurred within 3 h in five of six ponies and Van Weyenberg et al. [46] found that the passage of food through the equine stomach and small intestine takes 5 h on average. However, mean retention time is affected by diet and is increased in ponies fed on straw compared with those fed on hay [47] . Hence, although a fast of 12-14 h is sufficient in horses fed a typical racehorse diet [13] , it may be insufficient in those fed oaten hay, in which extended fasting may be required. Luthersson et al. [48] reported a fasting time of 17-23 h prior to gastroscopy in a nonracing population of horses, although it was still not possible to view the pylorus in 13 of 201 horses.
Conclusions
Four weeks of treatment with aloe vera inner leaf gel, at 17.6 mg/kg bwt b.i.d., was inferior to treatment with omeprazole buffered paste, at 4 mg/ kg bwt s.i.d., in the treatment of naturally occurring ESGD. Squamous lesions were less likely to heal in horses that showed prolonged gastric emptying.
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